Literature DB >> 22266237

Kindling-associated SV2A expression in hilar GABAergic interneurons of the mouse dentate gyrus.

Yukihiro Ohno1, Takahiro Okumura, Ryo Terada, Shizuka Ishihara, Tadao Serikawa, Masashi Sasa.   

Abstract

Immunohistochemical studies were performed to analyze the expressional changes in hippocampal synaptic vesicle protein 2A (SV2A) following pentylenetetrazole (PTZ) kindling. Repeated treatments of mice with sub-convulsive PTZ (40 mg/kg, i.p.) for 15 days progressively enhanced seizure susceptibility and induced clonic convulsions in most animals examined. Topographical analysis of hippocampal SV2A-immunoreactivity revealed that SV2A was densely expressed in the hilar region of the dentate gyrus, stratum lucidum of the CA3 field and around the periphery of CA3 pyramidal neurons. PTZ kindling region-specifically increased SV2A expression in the dentate hilus without affecting that in the stratum lucidum or the pyramidal cell layer of the CA3 field. Confocal laser microscopic analysis using PTZ-kindled mice illustrated that most SV2A was co-expressed with glutamic acid decarboxylase 67 in the cell bodies and dendrites of hilar interneurons. However, SV2A-immunoreactivity was negligibly observed in the hilar glutamatergic nerve terminals (mossy fibers) probed with the anti-vesicular glutamate transporter 1 antibody. The present study suggests that SV2A specifically regulates hilar GABAergic neurotransmission in the kindled hippocampus probably as a compensatory or prophylactic mechanism against kindling epileptogenesis.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266237     DOI: 10.1016/j.neulet.2012.01.009

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice.

Authors:  Eric W Fish; Abigail E Agoglia; Michael C Krouse; R Grant Muller; J Elliott Robinson; C J Malanga
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

2.  Association of Alpha-Soluble NSF Attachment Protein with Epileptic Seizure.

Authors:  Zhiqin Xi; Wanni Deng; Liang Wang; Fei Xiao; Jie Li; Zhihua Wang; Xin Wang; Xiujuan Mi; Na Wang; Xuefeng Wang
Journal:  J Mol Neurosci       Date:  2015-07-09       Impact factor: 3.444

3.  Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated with the Response to Levetiracetam Treatment.

Authors:  Itzel Jatziri Contreras-García; Gisela Gómez-Lira; Bryan Víctor Phillips-Farfán; Luz Adriana Pichardo-Macías; Mercedes Edna García-Cruz; Juan Luis Chávez-Pacheco; Julieta G Mendoza-Torreblanca
Journal:  Brain Sci       Date:  2021-04-23

4.  A Missense Mutation of the Gene Encoding Synaptic Vesicle Glycoprotein 2A (SV2A) Confers Seizure Susceptibility by Disrupting Amygdalar Synaptic GABA Release.

Authors:  Kentaro Tokudome; Takahiro Okumura; Ryo Terada; Saki Shimizu; Naofumi Kunisawa; Tomoji Mashimo; Tadao Serikawa; Masashi Sasa; Yukihiro Ohno
Journal:  Front Pharmacol       Date:  2016-07-14       Impact factor: 5.810

Review 5.  A review of the pharmacology and clinical efficacy of brivaracetam.

Authors:  Pavel Klein; Anyzeila Diaz; Teresa Gasalla; John Whitesides
Journal:  Clin Pharmacol       Date:  2018-01-19

Review 6.  Puzzling Out Synaptic Vesicle 2 Family Members Functions.

Authors:  Odile Bartholome; Priscilla Van den Ackerveken; Judit Sánchez Gil; Orianne de la Brassinne Bonardeaux; Pierre Leprince; Rachelle Franzen; Bernard Rogister
Journal:  Front Mol Neurosci       Date:  2017-05-22       Impact factor: 5.639

7.  Loss of Hippocampal Calretinin and Parvalbumin Interneurons in the 5XFAD Mouse Model of Alzheimer's Disease.

Authors:  Naomi K Giesers; Oliver Wirths
Journal:  ASN Neuro       Date:  2020 Jan-Dec       Impact factor: 4.146

8.  Expressional analysis of the astrocytic Kir4.1 channel in a pilocarpine-induced temporal lobe epilepsy model.

Authors:  Yuki Nagao; Yuya Harada; Takahiro Mukai; Saki Shimizu; Aoi Okuda; Megumi Fujimoto; Asuka Ono; Yoshihisa Sakagami; Yukihiro Ohno
Journal:  Front Cell Neurosci       Date:  2013-07-05       Impact factor: 5.505

9.  Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission.

Authors:  Kentaro Tokudome; Takahiro Okumura; Saki Shimizu; Tomoji Mashimo; Akiko Takizawa; Tadao Serikawa; Ryo Terada; Shizuka Ishihara; Naofumi Kunisawa; Masashi Sasa; Yukihiro Ohno
Journal:  Sci Rep       Date:  2016-06-06       Impact factor: 4.379

Review 10.  Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond.

Authors:  Wolfgang Löscher; Michel Gillard; Zara A Sands; Rafal M Kaminski; Henrik Klitgaard
Journal:  CNS Drugs       Date:  2016-11       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.